Longitudinal analysis of bone mineral density in pre-menopausal female systemic lupus erythematosus patients: Deleterious role of glucocorticoid therapy at the lumbar spine

Rheumatology

Volumn 39, Issue 4, 2000, Pages 389-392

  Jardinet, D ^a   Lefebvre C ^a   Depresseux, G ^a   Lambert, M ^a   Devogelaer, J P ^a   Houssiau, F A ^a  

^a CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

Author keywords

BMD; Glucocorticoids; Longitudinal; Osteoporosis; Pre menopausal females; SLE

Indexed keywords

GLUCOCORTICOID; PREDNISOLONE;

ADULT; ARTICLE; BONE ATROPHY; BONE DENSITY; BONE MINERAL; CLINICAL ARTICLE; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; HUMAN; LONGITUDINAL STUDY; LUMBAR SPINE; OSTEOPOROSIS; PREMENOPAUSE; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADULT; BONE DENSITY; FEMALE; HUMANS; LONGITUDINAL STUDIES; LUMBAR VERTEBRAE; LUPUS ERYTHEMATOSUS, SYSTEMIC; PREDNISOLONE; PREMENOPAUSE;

EID: 0034108046     PISSN: 14620324     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Kalla AA, Fataar AB, Jessop SJ, Bewerunge L. Loss of trabecular bone mineral density in systemic lupus erythematosus. Arthritis Rheum 1993;36:1726-34.
2. Formiga F, Moga I, Nolla JM, Pac M, Mitjavila F, Roig-Escofet D. Loss of bone mineral density in premenopausal women with systemic lupus erythematosus. Ann Rheum Dis 1995;54:274-6.
3. Pons F, Peris P, Guanabens N et al. The effect of systemic lupus erythematosus and long-term steroid therapy on bone mass in pre-menopausal women. Br J Rheumatol 1995;34:742-6.
4. Sels F, Dequeker J, Verwilghen J, Mbuyi-Muamba J-M. Viewpoint. SLE and osteoporosis: dependence and/or independence on glucocorticoids. Lupus 1996;5:89-92.
5. Houssiau FA, Lefebvre C, Depresseux G, Lambert M, Devogelaer J-P, Nagant de Deuxchaisnes C. Trabecular and cortical bone loss in systemic lupus erythematosus. Br J Rheumatol 1996;35:244-7.
6. Hansen M, Halberg P, Kollerup G et al. Bone metabolism in patients with systemic lupus erythematosus. Scand J Rheumatol 1998;27:197-206.
7. Kipen Y, Buchbinder R, Forbes A, Strauss B, Littlejohn G, Morand E. Prevalence of reduced bone mineral density in systemic lupus erythematosus and the role of steroids. J Rheumatol 1997;24:1922-9.
8. Li EK, Tam LS, Young RP, Ko GTC, Li M, Lau EMC. Loss of bone mineral density in Chinese pre-menopausal women with systemic lupus erythematosus treated with corticosteroids. BrJ Rheumatol 1998;37:405-10.
9. Formiga F, Nolla JM, Moga I, Roig-Escofet D. Sequential study of bone mineral density in patients with systemic lupus erythematosus. Ann Rheum Dis 1996;55:857.
10. Lukert BP, Raisz LG. Glucocorticoid-induced osteoporosis. Rheum Dis Clin North Am 1994;20:629-50.
11. Tan EM, Cohen AS, Fries JF et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25:1271-7.
12. Devogelaer JP, Le Thi C, Depresseux G, Nagant de Deuxchaisnes C. Reproducibility of bone mass measurements in human volunteers using three DPA and one dual-energy X-ray bone densitometers: correlation between instruments. In: Ring EFG, ed. Current research in osteoporosis and bone mineral measurements. London: British Institute of Radiology. 1987:36.
13. Compston JE, Judd D, Crawley EO et al. Osteoporosis in patients with inflammatory bowel disease. Gut 1987; 28:410-5.
14. Laan RF, van Riel PL, van de Putte LB, van Erning LJ, van't Hof MA, Lemmens JA. Low-dose prednisone induces rapid reversible axial bone loss in patients with rheumatoid arthritis. A randomized, controlled study. Ann Intern Med 1993;119:963-8.
15. Peel NFA, Moore DJ, Barrington NA, Bax DE, Eastell R. Risk of vertebral fracture and relationship to bone mineral density in steroid treated rheumatoid arthritis. Ann Rheum Dis 1995;54:801-6.
16. Reid IR. Pathogenesis and treatment of steroid osteoporosis. Clin Endocrinol (Oxf) 1989;30:83-103.
17. Nagant de Deuxchaisnes C, Devogelaer JP, Esselinckx W et al. The effect of low dosage glucocorticoids on bone mass in rheumatoid arthritis: a cross-sectional and a longitudinal study using single photon absorptiometry. Adv Exp Med Biol 1984;171:209-39.
18. Boutsen Y, Jamart J, Esselinckx W, Stoffel M, Devogelaer J-P. Primary prevention of glucocorticoid-induced osteoporosis with intermittent intravenous pamidronate: a randomized trial. Calcif Tissue Int 1997;61:266-71.
19. Saag KG, Emkey R, Schnitzer TJ et al. Alendronate for the prevention and treatment of glucocorticoid-induced osteoporosis. Glucocorticoid-induced Osteoporosis Intervention Study Group. N Engl J Med 1998;339:292-9.